BioElectronics Corporation (BIEL)

Market Cap	7.41M
Revenue (ttm)	1.61M
Net Income (ttm)	-289.82K
Shares Out	24.71B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,013,929
Open	0.0003
Previous Close	0.0003
Day's Range	0.0003 - 0.0003
52-Week Range	0.0001 - 0.0005
Beta	0.91
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About BioElectronics

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: BIEL

Financial Performance

In 2021, BioElectronics's revenue was $1.61 million, an increase of 94.01% compared to the previous year's $829,563. Losses were -$289,821, -75.01% less than in 2020.